Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$211 Sell
1
-180
-99% -$38.6K ﹤0.01% 212
2026
Q1
$40K Hold
181
0.04% 104
2025
Q4
$45.9K Buy
+181
New +$45.5K 0.04% 102

Other funds holding STE

CrossGen Wealth's STE Position: Q2 2026 in Review

CrossGen Wealth reduced its Steris (STE) stake by 99% in Q2 2026, selling an estimated $38.6K and leaving 1 share worth $211. The position accounts for ﹤0.01% of the portfolio, ranked #212.

CrossGen Wealth first reported a position in STE in Q4 2025 and has held it in 3 quarters since. The position peaked at $45.9K in Q4 2025. 830 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • CrossGen Wealth held 1 share of Steris worth $211 as of Q2 2026.
  • CrossGen Wealth sold 180 Steris shares in Q2 2026, an estimated $38.6K.
  • Steris made up ﹤0.01% of CrossGen Wealth's portfolio in Q2 2026, its #212 holding.
  • CrossGen Wealth first reported a position in Steris in Q4 2025 and has held it in 3 quarters since.
  • CrossGen Wealth's Steris position peaked at $45.9K in Q4 2025.
  • 830 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on CrossGen Wealth's 13F filing for Q2 2026, filed 24 Jul 2026.